Ticker Details
Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
IPO Date:	March 26, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$43.51B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 1.49%
Avg Daily Range (30 D):	$0.64 | 1.91%
Avg Daily Range (90 D):	$0.61 | 1.83%

Institutional Daily Volume
Avg Daily Volume:	7.7M
Avg Daily Volume (30 D):	4.59M
Avg Daily Volume (90 D):	4.92M

Trade Size
Avg Trade Size (Sh.):	233
Avg Trade Size (Sh.) (30 D):	100
Avg Trade Size (Sh.) (90 D):	102

Institutional Trades
Total Institutional Trades:	81,919
Avg Institutional Trade:	$2.34M
Avg Institutional Trade (30 D):	$4.11M
Avg Institutional Trade (90 D):	$4.94M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	14

Market Closing Trades
Avg Closing Trade:	$5.97M
Avg Closing Trade (30 D):	$17.67M
Avg Closing Trade (90 D):	$20.23M
Avg Closing Volume:	273.89K

News

Aug 3, 2026 @ 7:17 PM Ionis Pharmaceuticals Director Hayden Buys $1.1 Mi... Source: Brendan Coffey

Jul 9, 2026 @ 4:12 PM Novartis vs. Teva: Which Pharmaceutical Stock Is a... Source: Brendan Coffey

Jul 6, 2026 @ 5:09 PM Eli Lilly and vs. Teva: Which Pharmaceutical Stock... Source: Brendan Coffey

Jun 18, 2026 @ 9:00 PM Teva Releases Q2 2026 Aide Memoire Source: Na

Jun 18, 2026 @ 8:57 PM Teva Submits NDA for Ecopipam, a First-in-Class In... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.62	$-.49	$.32
Diluted EPS	$.6	$-.49	$.31
Revenue	$14.1B	$4.14B	$3.98B
Gross Profit	$9.08B	$2.15B	$1.97B
Net Income / Loss	$709M	$-575M	$369M
Operating Income / Loss	$1.6B	$-231M	$652M
Cost of Revenue	$8.23B	$1.99B	$2.01B
Net Cash Flow	$1.49B	$-86M	$185M
PE Ratio

Splits
Jul 01, 2004	2:1
Dec 06, 2002	2:1
Feb 23, 2000	2:1